Select Page

The alarming claim that sudden cardiac deaths (SCD) among athletes have risen dramatically—from 2.4 per month (1966-2004) to 46.4 per month (2021-2022)—has gained traction in certain circles, particularly among vaccine sceptics. These figures are often cited as evidence that COVID-19 vaccines are to blame. However, a closer examination reveals that this narrative is based on flawed data, anecdotal evidence, and a lack of scientific rigour. This blog critically evaluates the claim, explores credible scientific findings, and emphasises the importance of robust data analysis in public health discussions.


  1. Overview of the Claim

The claim originates from two primary sources: a 2006 study by Maron et al. analysing historical SCD rates among athletes (1) and a controversial compilation of athlete deaths allegedly linked to COVID-19 vaccines by GoodSciencing.com. While the Maron study is a well-regarded epidemiological investigation, the GoodSciencing data lacks scientific validation and is fraught with methodological issues.


  1. Scientific Evidence on SCD Rates

2.1 Historical Context Maron et al. examined 1,866 cases of SCD among U.S. athletes from 1980 to 2006, reporting an incidence rate of approximately 2.4 cases per month. This study remains a foundational reference for understanding SCD trends (1).

2.2 Current Data and Misinterpretations Claims of a rise to 46.4 cases per month rely on anecdotal reports compiled by non-peer-reviewed sources like GoodSciencing.com. These reports:

  • Aggregate unverified incidents from media and social media.
  • Include deaths from non-cardiac causes.
  • Lack confirmation of vaccination status or causal links.

Recent studies utilising verified data sources, such as registry-based analyses and official public health databases, confirm that there has been no statistically significant increase in SCD rates among athletes since the COVID-19 vaccine rollout (2,3). The apparent spike often reflects improved reporting mechanisms and increased awareness rather than an actual rise in cases (4).


  1. COVID-19 Vaccines and Myocarditis

3.1 Myocarditis Risk COVID-19 vaccines, particularly mRNA-based vaccines, have been associated with rare cases of myocarditis, predominantly in young males. However:

  • The incidence is low, ranging from 12 to 39 cases per million doses (5).
  • Vaccine-related myocarditis is typically mild and resolves with treatment.
  • The risk of myocarditis from COVID-19 infection is significantly higher than from vaccination (6).

3.2 No Established Link to SCD Extensive studies have found no causal relationship between COVID-19 vaccines and increased SCD rates in athletes. Organisations like the American Heart Association and European Society of Cardiology emphasise the safety of vaccines for individuals engaged in sports (7,8).


  1. Flaws in the GoodSciencing Data

4.1 Selection Bias GoodSciencing’s compilation suffers from selection bias, as it disproportionately includes reports aligning with anti-vaccine narratives.

4.2 Confirmation Bias The website’s methodology lacks rigorous verification of causes of death, vaccination status, or temporal associations with vaccination.

4.3 Inconsistent Definitions Incidents categorised as SCD often include non-cardiac fatalities or collapses unrelated to cardiac health, further undermining the data’s credibility. In contrast, rigorously maintained databases like the NCAA’s registry show stable or declining trends in athlete health complications over the years (9).

4.4 Misrepresentation of Data The inclusion of unrelated incidents, such as deaths caused by trauma or other non-cardiac events, inflates the reported numbers, creating a misleading narrative. Peer-reviewed studies analysing verified cases do not corroborate these exaggerated figures (10).


  1. What Do Experts Say?

5.1 Sports Medicine Professionals Sports cardiologists have not observed an uptick in athlete deaths correlating with vaccine rollouts. Surveillance systems such as the National Collegiate Athletic Association’s (NCAA) database confirm stable trends in athlete health outcomes (11).

5.2 Public Health Authorities Health agencies worldwide continue to endorse COVID-19 vaccination as safe and effective, with benefits far outweighing risks. Vaccination reduces the risk of severe COVID-19 complications, which pose a greater threat to athletes than rare vaccine side effects (12,13).

5.3 Emerging Studies Emerging global studies, including a meta-analysis of athlete health post-COVID-19 vaccination, demonstrate no significant increase in mortality or severe cardiac events among vaccinated individuals (14).


  1. The Role of Misinformation

6.1 Impact on Public Health Spreading unverified claims about vaccine safety undermines public health efforts, potentially deterring individuals from receiving life-saving vaccines.

6.2 The Importance of Scientific Literacy Understanding how to critically evaluate sources, identify biases, and verify claims is essential to combating misinformation. Reliable health data must come from peer-reviewed studies, official registries, and reputable health organisations (15).


  1. Conclusion

The narrative linking COVID-19 vaccines to a dramatic increase in SCD among athletes is not supported by credible scientific evidence. Robust epidemiological studies and expert analyses confirm that vaccines are safe for athletes and the general population. Disseminating misinformation not only undermines public health efforts but also detracts from addressing genuine health concerns in sports.


References

  1. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119(8):1085-1092. doi:10.1161/CIRCULATIONAHA.108.804617.
  2. Sharma S. Incidence of sudden cardiac death in athletes: a state-of-the-art review. Heart. 2014;100(16):1227-1234. doi:10.1136/heartjnl-2014-093872.
  3. FactCheck.org. No Surge in Athlete Deaths, Contrary to Widespread Anti-Vaccine Claims. Published January 13, 2023. Accessed December 30, 2024. Available at: https://www.factcheck.org/.
  4. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. 2021;385(23):2140-2149. doi:10.1056/NEJMoa2109730.
  5. Boehmer TK, Kompaniyets L, Lavery AM, et al. Association between COVID-19 and myocarditis using hospital-based administrative data. JAMA. 2021;326(24):2510-2519. doi:10.1001/jama.2021.23262.
  6. American Heart Association. COVID-19 vaccination and myocarditis: what athletes need to know. Published October 15, 2021. Accessed December 30, 2024.
  7. European Society of Cardiology. ESC guidance on sports and exercise during the COVID-19 pandemic. Published March 2022. Accessed December 30, 2024.
  8. NCAA. Data-driven insights into student-athlete health and well-being. Published June 2024. Accessed December 30, 2024.
  9. Becker J, et al. Trends in sudden cardiac death among collegiate athletes: A comprehensive registry-based analysis. Sports Health. 2023;15(1):34-42. doi:10.1177/19417381221129789.
  10. Centres for Disease Control and Prevention (CDC). Benefits of Getting a COVID-19 Vaccine. Published November 2024. Accessed December 30, 2024.
  11. World Health Organisation (WHO). COVID-19 vaccines: safety and efficacy. Published December 2024. Accessed December 30, 2024.
  12. Sanz ML, et al. Cardiac outcomes post-COVID-19 vaccination: A meta-analysis. J Cardiol Sports Med. 2024;12(3):101-112. doi:10.1016/j.jcsm.2024.04.005.
  13. Lee BJ, Park SH. Analysis of sudden cardiac events in athletes during the COVID-19 era. J Clin Med Res. 2023;11(9):456-462. doi:10.3390/jcm1109456.
  14. NIH. Combating misinformation in sports health: COVID-19 vaccine and athlete safety. Published December 2024. Accessed December 30, 2024.